This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;41(1):15-25.
doi: 10.1007/s12026-007-8012-y.

L-arginine metabolism and its impact on host immunity against Leishmania infection

Affiliations
Review

L-arginine metabolism and its impact on host immunity against Leishmania infection

Nanchaya Wanasen et al. Immunol Res. 2008.

Abstract

Leishmaniasis is a vector-borne disease found in many countries worldwide. The causative agent of the disease, Leishmania spp., lives as an obligate intracellular parasite within mammalian hosts. Since tissue macrophages are major target cells for parasite replication, the outcome of infection depends largely on the activation status of these cells. L-arginine is a crucial amino acid required for both nitric oxide (NO)-mediated parasite killing and polyamine-mediated parasite replication. This review highlights the significance of L-arginine as a factor determining the outcomes of Leishmania infection in vitro and its influences on host immune responses in vivo. Various therapeutic approaches targeting L-arginine metabolic pathways during infections with Leishmania are also discussed.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
L-arginine metabolic pathways and their influence on Leishmania infection. Classical activation of MΦs via stimulation of Th1 cytokines (IFN-γ plus LPS or IFN-γ plus TNF-α) results in an enhanced expression of CAT-2B, increased L-arginine availability and iNOS activity, ultimately leading to parasite killing. Conversely, Th2-mediated activation of MΦs (via IL-4, IL-13, and TGF-β) enhances CAT-2B expression and arginase activity, resulting in parasite growth. In suboptimally activated MΦs (primed by low concentrations of IFN-γ), CAT-2B is moderately induced, but iNOS and arginase remain relatively inactivated, allowing Leishmania amastigotes (Am) to take up and use available L-arginine for their proliferation. While it is unclear which molecules are responsible for the transport of L-arginine across the parasitophorous (PV) membrane, at least one permease, LdAAP3, has been identified as a transporter of L-arginine across the membrane of L. donovani promastigotes. Once inside the amastigotes, L-arginine can be utilized by parasite-derived NOS or arginase. While Leishmania-derived arginase is involved in polyamine synthesis necessary for the parasite growth, the exact role of Leishmania-derived NOS during infection is unclear

References

    1. Bogitsh BJ, Carter CE, Oeltmann TN. Human Parastiology. 3rd ed. Elsevier Academic Press; Burlington: 2005. Blood and tissue protozoa I: hemaflagellates. pp. 101–14. Chapter 6.
    1. Moll H, Flohe S, Rollinghoff M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol. 1995;25:693–9. - PubMed
    1. Bogdan C, Donhauser N, Doring R, Rollinghoff M, Diefenbach A, Rittig MG. Fibroblasts as host cells in latent leishmaniosis. J Exp Med. 2000;191:2121–30. - PMC - PubMed
    1. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, Laskay T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol. 2004;173:6521–5. - PubMed
    1. Noel W, Raes G, Hassanzadeh GG, De Baetselier P, Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004;20:126–33. - PubMed

MeSH terms

Cite

AltStyle によって変換されたページ (->オリジナル) /